Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05338970 |
|---|---|
| Brief Title: | HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy |
| First Submitted : | April 15, 2022 |
| First Submitted that Met QC Criteria : | April 20, 2022 |
| First Posted : | April 21, 2022 |
| Last Update Submitted that Met QC Criteria : | April 16, 2024 |
| Last Update Posted : | April 19, 2024 |